Andera Partners

EG 427 is a French biotechnology company that specializes in pinpoint gene therapy, aimed at treating disorders related to spinal cord injuries. The company utilizes HSV-1-based vectors, leveraging the natural characteristics of the Herpes Simplex Virus 1 to establish lifelong latency in peripheral neurons. This innovative approach allows for targeted and sustained expression of therapeutic genes, providing a potential cure for severe, chronic, and localized conditions, such as neurogenic bladder disorders resulting from spinal cord injuries. By focusing on this advanced gene therapy technique, EG 427 seeks to improve treatment outcomes for patients suffering from these debilitating conditions.

Ayming is a management consulting firm headquartered in Levallois, France, that focuses on optimizing operational performance for its clients. The company provides a range of services, including consulting on human resources costs, tax strategies, operational costs optimization, software solutions, and energy and environmental issues. Additionally, Ayming offers advisory services related to work contributions and wage audits. By leveraging these diverse consulting offerings, Ayming aims to help organizations enhance their efficiency and overall performance while effectively managing social costs associated with taxes and financial operations.

ENYO Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, that focuses on the discovery and development of innovative treatments for acute and chronic viral infections. Established in 2014 by a team of scientists from the Infectiology Research Center, the company utilizes a proprietary platform to identify intracellular therapeutic targets and develop small molecule therapeutics. ENYO Pharma's research primarily targets significant human infecting viruses, with current programs aimed at treating chronic hepatitis B and severe influenza. The company's pipeline includes a lead compound, EYP001, which modulates FXR to reduce the cccDNA reservoir and inhibit the expression of viral proteins, along with EYP002, which is in preclinical studies. With an emphasis on addressing unmet medical needs in infectious diseases and metabolic disorders, ENYO Pharma has established collaborations with prominent research institutions to enhance its drug development efforts.

Andera Partners, founded in 2001 and based in Paris, France, is a private equity firm that specializes in investing in growth-stage companies. The firm focuses on a diverse range of sectors, including sustainable energy, transportation and logistics, agribusiness, business-to-business and business-to-consumer services, building and construction, cosmetics, distribution, information technology and software, media, medical technology, real estate, therapeutic products, and tourism. Andera Partners employs a strategy centered on buyouts, aiming to support companies with innovative solutions and sustainable growth potential. With a commitment to fostering long-term performance, the firm leverages its expertise and experience to anticipate market trends and cultivate valuable relationships with its portfolio companies.

HR Path is a global consultancy focused on human resources, with a workforce of over 500 consultants operating in North America, Europe, and the Middle East. The company specializes in HR Systems Integration, HR Outsourcing, and HR Business Consulting. It offers human capital management technology and is an authorized reseller of various software solutions in France, including SAP, SuccessFactors, Oracle HCM, and others. Additionally, HR Path has developed proprietary HR software solutions such as BiHRdy, a business intelligence tool, Pandore, which integrates HR, payroll, and time management, and Geef, a talent management system. The company's diverse client portfolio includes several prominent companies listed on the CAC 40, as well as small and medium-sized enterprises and public sector organizations. HR Path is dedicated to supporting businesses throughout their digital transformation by enhancing human resource operations through innovative technology.

Lhyfe is a company based in Nantes, France, that specializes in the design, development, and operation of industrial sites for the production of green hydrogen using renewable energy sources such as wind and solar power. Founded in 2017, Lhyfe aims to provide substantial quantities of clean and affordable hydrogen, facilitating the transition of various industrial sectors and transportation towards a sustainable energy framework. The company focuses on two primary markets: heavy mobility, including trucks, buses, trains, and potentially maritime and air transport, as well as industrial applications, targeting industries such as chemistry, steel, and glass production. By integrating its production facilities with available renewable energy sources, Lhyfe ensures a minimal environmental footprint while addressing the urgent need to reduce greenhouse gas emissions.

Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.

Medlumics S.L., founded in 2009 and based in Tres Cantos, Spain, specializes in designing and manufacturing catheter-based systems for the treatment of supraventricular tachycardias. The company focuses on developing integrated photonic devices that utilize optical coherence tomography technology, a light-based diagnostic method providing detailed information about tissue structures. Medlumics' radiofrequency cardiac ablation system enhances the treatment process by delivering real-time visual confirmation of catheter contact and stability during tissue ablation. This innovation aims to reduce recurrence rates and technical complexity in procedures, ultimately increasing safety for patients undergoing cardiac interventions.

Sogetrel, S.A.S. specializes in designing, deploying, and maintaining network infrastructures and digital communication solutions. Founded in 1985 and headquartered in Issy les Moulineaux, France, the company serves various sectors, including telecommunications, public authorities, defense, transport, and utilities. Sogetrel offers a range of services, such as the integration of communication systems, installation of telecommunication networks, and implementation of IP security measures like video surveillance and access control. Additionally, the company provides consultancy for smart city projects, along with supervision and image analysis services. With a focus on enhancing the quality of life for citizens and improving operational efficiency for businesses, Sogetrel has established itself as a key partner for major operators and local authorities, particularly in the deployment of high-speed networks. The company also has branches in Belgium and Switzerland, reinforcing its presence in the European market.

MasterGrid, based in Grenoble, France, specializes in the manufacture and supply of high voltage electrical equipment tailored for the commercial and industrial sectors. Established in 2019, the company produces a range of products including high, medium, and low-voltage equipment designed for the distribution, protection, control, and management of electrical systems. In addition to manufacturing, MasterGrid offers equipment handling services, ensuring that clients receive safe and durable products that enhance performance and efficiency.

Olaqin is a healthcare service provider based in Suresnes, France, specializing in value-added e-health solutions for health professionals. The company caters to various sectors within the healthcare industry, offering services such as centralized payment, securing electronic care sheets, updating vital cards, and safeguarding access to online medical records. Olaqin operates through a distribution network that supports health professionals indirectly, while also engaging directly with public hospitals and pharmacies through service contracts. This comprehensive approach ensures that clients receive essential facilities, including biometrics and management support, enhancing the efficiency and security of healthcare operations.

Ellisphere is a reference for decision-making information, supporting and securing the decision-making of company executives and decision-makers in France and internationally via the BIGnet network, by providing them with economic and financial information on their trading partners.

HR Path is a global consultancy focused on human resources, with a workforce of over 500 consultants operating in North America, Europe, and the Middle East. The company specializes in HR Systems Integration, HR Outsourcing, and HR Business Consulting. It offers human capital management technology and is an authorized reseller of various software solutions in France, including SAP, SuccessFactors, Oracle HCM, and others. Additionally, HR Path has developed proprietary HR software solutions such as BiHRdy, a business intelligence tool, Pandore, which integrates HR, payroll, and time management, and Geef, a talent management system. The company's diverse client portfolio includes several prominent companies listed on the CAC 40, as well as small and medium-sized enterprises and public sector organizations. HR Path is dedicated to supporting businesses throughout their digital transformation by enhancing human resource operations through innovative technology.

Tournus Equipement, S.A.S. is a manufacturer based in Tournus, France, specializing in stainless steel environments for professional kitchens and supermarket fish counters. The company provides a wide range of products, including mobile and modular kitchens, regeneration ovens, warmers, sterilizing cabinets, and various kitchen units. It also designs and manufactures equipment such as trolleys, containers, wash-basins, dishwashing equipment, and shelving products. Tournus Equipement serves diverse sectors, including canteens, restaurants, bakeries, supermarkets, and transport catering services. In addition to its manufacturing capabilities, the company offers joint design, installation, and express delivery services, catering to the specific needs of its clients. Founded in 1910, Tournus Equipement is known for its commitment to quality and durability in commercial kitchen solutions.

Verbraeken Infra builds and renovates utility infrastructure networks for gas, water, electricity and telecom companies. Vebraeken-Infra generates sales of € 140 million annually, with 1.000 employees across Belgium, France and Germany. Waterland supports Infra Group in its continued expansion in Europe and beyond. This growth strategy resulted in expansion of Verbraeken-Infra’s footprint both organically as well as through acquisitions in France, Germany and the Benelux and has strengthened Verbraeken-Infra’s leading market position in Belgium.

Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.

The Bioclinic Group is a medical company that operates medical analysis laboratories. It was founded in 1995 and is based in Paris, France.

Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.

Skill & You is a prominent provider of vocational e-learning in France, focusing on delivering effective education and recognized qualifications such as BAC PRO, BEP, BP, BTS, and CAP. The company addresses the pressing issue of employment by offering a range of customized online courses that cater to the evolving needs of both learners and businesses. Its platform emphasizes adaptability and innovation, enabling users to acquire professional skills necessary for job adaptation, skill enhancement, and personal development. With a strong track record across various sectors, Skill & You empowers individuals to improve their lives through education, leveraging extensive expertise and a commitment to professionalism.

ENYO Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, that focuses on the discovery and development of innovative treatments for acute and chronic viral infections. Established in 2014 by a team of scientists from the Infectiology Research Center, the company utilizes a proprietary platform to identify intracellular therapeutic targets and develop small molecule therapeutics. ENYO Pharma's research primarily targets significant human infecting viruses, with current programs aimed at treating chronic hepatitis B and severe influenza. The company's pipeline includes a lead compound, EYP001, which modulates FXR to reduce the cccDNA reservoir and inhibit the expression of viral proteins, along with EYP002, which is in preclinical studies. With an emphasis on addressing unmet medical needs in infectious diseases and metabolic disorders, ENYO Pharma has established collaborations with prominent research institutions to enhance its drug development efforts.

BIOGROUP-LCD, a major French player in local medical biology, supports more than 20,000 patients every day and offers more than 2000 routine and specialized daily examinations, based on performance and technological innovation. Partner at every moment between the patient and the medical profession, your laboratory participates in the screening, diagnosis, monitoring and prognosis of the most common pathologies to the most demanding, throughout your course of care. BIOGROUP-LCD develops for this purpose all its human and technological resources. The team of qualified, qualified medical biologists follows continuous and regular training.

Created in 2016, TimeOne is a marketing services group formed from two online marketing specialists, Public-Idées and Place des Leads. The group’s core offering is to provide content and data solutions. With a well-established reputation in prescriptive marketing and a common technological base (DMP), TimeOne is founded on innovation and realized through research and development. TimeOne offers a comprehensive range of online marketing solutions: Programmatic, Native, Performance, digital Marketplace, Publishing and Mobile. The company has a presence in France, in the United-Kingdom, in Spain, Italy, South Africa, Asia and South America.

GLOBE Groupe is a Paris-based agency that specializes in advertising services and strategic marketing. The company offers a range of services including communication strategy, talent castings, recruitment, training, payroll, and various logistical solutions such as storage, dispatch, and cold-chain logistics. GLOBE focuses on shopper marketing, implementing experiences that convert consumers into shoppers while assessing campaign effectiveness through established performance indicators. They utilize a comprehensive methodology to evaluate the impact of their marketing efforts, ensuring that all operations are tracked through a secure extranet platform, myGLOBE, which provides real-time updates and data confidentiality. The company serves diverse sectors including consumer goods, media, and retail, aiming to enhance brands' commercial transformation and drive sales growth for its clients.

Allodiagnostic SAS, based in Paris, France, specializes in providing essential real estate diagnostics, including assessments for termites, electrical systems, and energy performance. Founded in 2001, the company caters to private individuals during the sale or rental of properties. It serves as a key resource for both consumers and real estate professionals, offering tailored solutions to meet various diagnostic requirements. As of July 2017, Allodiagnostic operates as a subsidiary of Edmond de Rothschild (France).

Intech is a leading manufacturer of orthopedic instruments and implants dedicated to enhancing patient outcomes. Operating with a workforce of around 1,000 employees globally, the company provides comprehensive manufacturing solutions to medical device original equipment manufacturers (OEMs). Intech specializes in a wide range of surgical tools, including implants, sterilization cases, and trays, catering to various medical fields such as spine, hip, knee, sports medicine, and trauma surgery. With facilities located in the United States, France, and Malaysia, Intech is positioned as a one-stop shop for medical device OEMs, delivering both off-the-shelf and custom-made instruments efficiently and cost-effectively.

Groupe 3S SAS, through its subsidiaries, provides ground handling for airlines and services to airport managers. The company offers ground handling services, including passenger, baggage handling, load control and dispatch, ramp activity, and crew handling services; and airport services, such as assistance to persons with disabilities or with reduced mobility, management of taxis areas, baggage trolleys, airports cleaning, aircraft de-icing, runway and areas cleanliness, safety, and others services. It also provides industrial cleaning, cleanliness, ultra-cleanliness, and facility management services, and home support services to individuals; and aviation security, dangerous goods, and ground handling training courses. The company was founded in 2001 and is based in Roissy-en-France, France. Groupe 3S SAS is a prior subsidiary of Latécoère S.A.

Medlumics S.L., founded in 2009 and based in Tres Cantos, Spain, specializes in designing and manufacturing catheter-based systems for the treatment of supraventricular tachycardias. The company focuses on developing integrated photonic devices that utilize optical coherence tomography technology, a light-based diagnostic method providing detailed information about tissue structures. Medlumics' radiofrequency cardiac ablation system enhances the treatment process by delivering real-time visual confirmation of catheter contact and stability during tissue ablation. This innovation aims to reduce recurrence rates and technical complexity in procedures, ultimately increasing safety for patients undergoing cardiac interventions.

Mondial Pet Distribution S.p.A., located in Fossano, Italy, specializes in the distribution of hygiene and personal care products for animals, primarily under the Fortesan brand. The company focuses on providing high-quality products that cater to the needs of pet owners and their animals. As of April 2018, it operates as a subsidiary of Agrifarma S.p.A.

Ipside is a firm that provides comprehensive assistance and advice to clients on patent acquisition, operation, and defense, both in France and internationally. The company specializes in various sectors, including telecommunications, software, aerospace, pharmaceuticals, biotechnology, and optoelectronics. In addition to patent services, Ipside offers litigation and consultancy related to patent law, trademark law, design law, copyright law, and software rights. The firm helps clients develop technical and legal strategies to protect their inventions, ensuring an effective approach to intellectual property that aligns with their overall business objectives.

Sogetrel, S.A.S. specializes in designing, deploying, and maintaining network infrastructures and digital communication solutions. Founded in 1985 and headquartered in Issy les Moulineaux, France, the company serves various sectors, including telecommunications, public authorities, defense, transport, and utilities. Sogetrel offers a range of services, such as the integration of communication systems, installation of telecommunication networks, and implementation of IP security measures like video surveillance and access control. Additionally, the company provides consultancy for smart city projects, along with supervision and image analysis services. With a focus on enhancing the quality of life for citizens and improving operational efficiency for businesses, Sogetrel has established itself as a key partner for major operators and local authorities, particularly in the deployment of high-speed networks. The company also has branches in Belgium and Switzerland, reinforcing its presence in the European market.

REALEASE Capital provides leasing and financing solutions primarily for manufacturers of videoconference materials and a variety of technological assets, including IT, telecom, industrial, audiovisual, medical, media, and digital equipment. Founded in 1986 and headquartered in Puteaux, France, the company specializes in progressive rental options that support businesses in acquiring the necessary technology without significant upfront costs. Formerly known as Comiris Capital, REALEASE Capital has established itself as a key player in the financing sector for technological advancements.

Groupe ERGET SA, founded in 1986 and headquartered in Neuilly-sur-Seine, France, specializes in surveying and loss adjustment services for various sectors, including cargo, property, and liability risks. The company provides technical risk assessments and expertise in fields such as construction, aviation, energy, industrial safety, and product liability. With a workforce of 120 collaborators, including 85 multidisciplinary surveyors, Groupe ERGET has expanded its international presence since 2006, operating teams in Asia, South America, and the West Indies, alongside a joint venture in over 30 African countries. The company has successfully conducted more than 5,500 missions across 115 countries, serving clients that include insurers, brokers, industrialists, and legal professionals. With a reported turnover of 20 million euros, 35% of which is generated from international markets, Groupe ERGET is recognized as a leader in the francophone market and continues to pursue growth opportunities in emerging regions.

ACE Group is a French mortgage broker.

ACE Group is a French mortgage broker.

Emeraude International SA is a distributor of polymers and chemicals, specializing in a wide range of products for various applications. The company provides polyolefins and thermoplastic lines, including blown film extrusion polymers used in agricultural and flexible packaging, blow molding polymers for beverage and cosmetic containers, and pipe extrusion polymers for liquid and gas applications. Additionally, it offers polypropylene extrusion polymers for industrial fibers and raffia tapes, as well as injection polymers for a variety of household and industrial items. Emeraude International also supplies chemicals and additives for food, paints, agriculture, personal care, and cleaning solutions. Beyond product distribution, the company offers supply chain solutions and finance support, serving customers primarily in Africa, the Indian subcontinent, Europe, and Southeast Asia. Founded in 1986 and headquartered in Paris, France, Emeraude International has expanded its operations with additional offices in France and internationally.

Finsecur S.A. is a French company based in Paris that specializes in the design, manufacture, and maintenance of fire-detection systems. Established in 2000, it offers a range of products including detectors, control panels, and accessories, as well as comprehensive fire alarm systems such as home fire detectors, extinguishing systems, and smoke clearing panels. Additionally, the company provides technical alarms for monitoring defects and anomalies in installations, including alarm panels and sprinkler system monitoring. Finsecur's products cater to various sectors, including clean rooms, telecoms, airports, and military industries. The company has been recognized for its innovation and growth, having received the BPI label Excellence, which connects it with a network of leading French companies in technology.

A2iA S.A. specializes in the development of advanced software tools for handwritten and machine-printed text recognition, information extraction, and intelligent document classification. Its product offerings include a2ia Mobility, which supports various workflows such as mobile remote deposit capture and ID verification; a2ia mNote, designed for offline conversion of handwritten notes into digital formats; and a2ia DocumentReader, which extracts data from both structured and unstructured documents. Additional tools include a2ia TextReader for transcribing printed and cursive handwriting, a2ia CheckReader for automated data capture from payment documents, and a2ia FieldReader for extracting information from forms. A2iA caters to a diverse clientele across sectors such as banking, fintech, telecom, healthcare, and government, serving markets in Europe, North America, Latin America, the Middle East, Africa, India, and the Asia Pacific. Founded in 1991 and headquartered in Paris, with an office in New York, A2iA operates as a subsidiary of Mitek Systems, Inc.

Maesa Group is designs and manufactures various tailor-made perfumes, cosmetics, and promotional products in France, rest of Europe, Asia, and North America. The company is involved in the brand identity, industrial design, package design, graphic design, and component creation activities; and design and manufacture of turnkey beauty products and home fragrance products for retailers and brands.

Thomson Video Networks SAS specializes in delivering comprehensive video solutions for broadcasters globally, focusing on various platforms including satellite, terrestrial, IPTV, and mobile TV. The company offers a wide range of products, including video compression systems such as HD and SD encoders, multiscreen video systems, and contribution codec platforms. Additionally, it provides processing and multiplexing systems, MPEG stream servers, and video decoding systems tailored for various broadcast applications. Thomson Video Networks also supplies data casting systems, monitoring and switching solutions, and integration and technical support services. Established in 2010 and headquartered in Cesson-Sevigne, France, the company operates as a subsidiary of Harmonic Inc., having previously been part of Grass Valley USA, LLC.

Groupe ADF SAS is an industrial maintenance and engineering services provider based in Vitrolles, France, founded in 1962. The company specializes in delivering maintenance solutions across various sectors, including aeronautics, space and defense, energy, and oil and gas. Its offerings encompass a wide range of services such as maintenance for the petrochemical and metallurgical industries, naval and port repairs, and pharmaceutical and agro-food sectors. Additionally, Groupe ADF provides turn-key solutions, revamping work, management of statutory stoppage work, and environmental services like waste management and industrial cleaning. The company is also involved in equipment integration and digital transformation to enhance production support and automate business processes.

Poxel is a dynamic biopharmaceutical company developing innovative drugs for metabolic diseases, with a focus on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Based in Lyon, France, Poxel was spun out in 2009 from Merck Serono, a global leader in the field of metabolic disorders at that time. They believe that targeting cellular energy regulation pathways for the treatment of metabolic diseases, including type 2 diabetes is of critical importance as disbalances are at the root of those diseases. All three of their clinical stage pipeline programs address significant targets in the energy metabolism pathways. Imeglimin, their lead program, targets mitochondrial dysfunction, mitochondria being the power station of the cell, PXL770 activates the adenosine monophosphate-activated protein kinase (AMPK), an important energy sensor, and PXL065 (DRX-065) inhibits the mitochondrial pyruvate carrier (MPC).

OCEAN SAS provides vehicle tracking solutions in France.

Novamex S.A. produces natural and eco-friendly cleaning, washing, and personal hygiene products to individuals and companies in France. It offers washing powders and liquids, cleaning liquids, shampoos, moisturizers, and hair conditioning products.

SuperSonic Imagine SA is a medical technology company that specializes in developing and manufacturing advanced ultrasound imaging systems. Founded in 2005 and headquartered in Aix-en-Provence, France, the company is renowned for its Aixplorer system, which provides high-definition imaging and is particularly effective in diagnosing and monitoring breast, prostate, and thyroid cancers, as well as liver diseases. The Aixplorer system incorporates ShearWave technology, enabling quantitative elastography that measures tissue elasticity. SuperSonic Imagine operates primarily in markets such as China, the United States, and various European countries, distributing its products through a network of offices and distributors. As a subsidiary of Hologic Hub Ltd, the company continues to innovate in the field of medical imaging, enhancing the capabilities of healthcare professionals.

Garden Price is a Les Nouvelles Jardineries, a Maurepas, France-based chain of low-cost garden stores.

Implanet S.A. is a French company that designs, manufactures, and sells a range of orthopedic surgical implants and devices. Founded in 2006 and based in Martillac, it operates primarily in France, the United States, Brazil, and other international markets. The company's product offerings include spinal implants, arthroscopic devices, and knee prostheses, with notable products such as the Jazz series for posterior fixation and the Madison knee prosthesis for conventional surgical techniques. Implanet aims to provide high-quality implants that enhance the productivity of healthcare professionals while addressing the need to reduce healthcare costs. Its business model emphasizes social and economic responsibility, ensuring a secure and informative environment for the healthcare community.

Poxel is a dynamic biopharmaceutical company developing innovative drugs for metabolic diseases, with a focus on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Based in Lyon, France, Poxel was spun out in 2009 from Merck Serono, a global leader in the field of metabolic disorders at that time. They believe that targeting cellular energy regulation pathways for the treatment of metabolic diseases, including type 2 diabetes is of critical importance as disbalances are at the root of those diseases. All three of their clinical stage pipeline programs address significant targets in the energy metabolism pathways. Imeglimin, their lead program, targets mitochondrial dysfunction, mitochondria being the power station of the cell, PXL770 activates the adenosine monophosphate-activated protein kinase (AMPK), an important energy sensor, and PXL065 (DRX-065) inhibits the mitochondrial pyruvate carrier (MPC).

Implanet S.A. is a French company that designs, manufactures, and sells a range of orthopedic surgical implants and devices. Founded in 2006 and based in Martillac, it operates primarily in France, the United States, Brazil, and other international markets. The company's product offerings include spinal implants, arthroscopic devices, and knee prostheses, with notable products such as the Jazz series for posterior fixation and the Madison knee prosthesis for conventional surgical techniques. Implanet aims to provide high-quality implants that enhance the productivity of healthcare professionals while addressing the need to reduce healthcare costs. Its business model emphasizes social and economic responsibility, ensuring a secure and informative environment for the healthcare community.

Genticel is a French clinical-stage biotechnology company established in 2001 by Benedikt Timmerman. The company specializes in developing innovative immunotherapies aimed at treating viral infections and diseases associated with viruses. Genticel focuses particularly on human papillomavirus (HPV) and HPV-induced conditions, such as cervical cancer. Its research includes advanced therapeutic vaccines and immunotherapy products, including a proprietary technological platform designed to enhance treatment efficacy. Genticel aspires to lead in the immunotherapy sector across various medical indications, with an initial emphasis on addressing the challenges posed by HPV and related health issues.

Smile is a provider of software integration and maintenance services based in Levallois-Perret, France. The company specializes in open source solutions, aiming to unlock innovation potential for businesses by leveraging its technical and business expertise. Smile's offerings encompass a wide range of areas, including digital evolution, business applications, embedded technologies, the Internet of Things (IoT), and infrastructure management. By focusing on these domains, Smile helps organizations optimize their operations and enhance their digital capabilities.

Implanet S.A. is a French company that designs, manufactures, and sells a range of orthopedic surgical implants and devices. Founded in 2006 and based in Martillac, it operates primarily in France, the United States, Brazil, and other international markets. The company's product offerings include spinal implants, arthroscopic devices, and knee prostheses, with notable products such as the Jazz series for posterior fixation and the Madison knee prosthesis for conventional surgical techniques. Implanet aims to provide high-quality implants that enhance the productivity of healthcare professionals while addressing the need to reduce healthcare costs. Its business model emphasizes social and economic responsibility, ensuring a secure and informative environment for the healthcare community.

SuperSonic Imagine SA is a medical technology company that specializes in developing and manufacturing advanced ultrasound imaging systems. Founded in 2005 and headquartered in Aix-en-Provence, France, the company is renowned for its Aixplorer system, which provides high-definition imaging and is particularly effective in diagnosing and monitoring breast, prostate, and thyroid cancers, as well as liver diseases. The Aixplorer system incorporates ShearWave technology, enabling quantitative elastography that measures tissue elasticity. SuperSonic Imagine operates primarily in markets such as China, the United States, and various European countries, distributing its products through a network of offices and distributors. As a subsidiary of Hologic Hub Ltd, the company continues to innovate in the field of medical imaging, enhancing the capabilities of healthcare professionals.

EOS imaging is a medical company revolutionizing the treatment continuum for the most common osteoarticular conditions (hip, knee and spine) and associated orthopedic surgeries. Its EOS® 2D/3D imaging system is specifically adapted to the needs of orthopedic surgeons and radiologists. This personalized imaging tool gives a precise 3D image of the patient's skeleton in the upright position that can be used to inform all aspects of care. The Company has obtained authorization to market the system in 48 countries. The Company is based in Paris, with a subsidiary in the United States in Cambridge, Massachusetts, as well as offices in Montreal (Canada) and Germany.

Implanet S.A. is a French company that designs, manufactures, and sells a range of orthopedic surgical implants and devices. Founded in 2006 and based in Martillac, it operates primarily in France, the United States, Brazil, and other international markets. The company's product offerings include spinal implants, arthroscopic devices, and knee prostheses, with notable products such as the Jazz series for posterior fixation and the Madison knee prosthesis for conventional surgical techniques. Implanet aims to provide high-quality implants that enhance the productivity of healthcare professionals while addressing the need to reduce healthcare costs. Its business model emphasizes social and economic responsibility, ensuring a secure and informative environment for the healthcare community.

Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-Allâ„¢ to identify orthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-Allâ„¢ is able to address difficult GPCRs such as orphan and peptidic GPCRs.

Cytomics Systems is a French private company that offers bio-pharmacology services. The company uses Yeast Micro-Lab technology, a protenomics tool, which enables to follow in-vitro deterioration of proteins. Cytomics Systems's research and development focuses on fungicidal infections, inflammatory illnesses, and cancers. Cytomics Systems, S.A was founded in 2000 and is based in Gif-sur-Yvette, France.

Cellectis S.A. is a clinical-stage biotechnological company headquartered in Paris, France, focused on developing immuno-oncology products utilizing gene-edited T-cells that express chimeric antigen receptors to target cancer cells. The company's primary portfolio includes several allogeneic T-cell product candidates such as UCART19, designed for treating CD19-expressing hematologic malignancies, and UCART123 for acute myeloid leukemia. Additional candidates include ALLO-501 for relapsed/refractory diffuse large B-cell lymphoma, UCART22 for B-cell acute lymphoblastic leukemia, and products targeting multiple myeloma, such as UCARTCS1 and ALLO-715. In addition to its therapeutic developments, Cellectis also produces high oleic soybean oil and other agricultural products. The company has established strategic partnerships with various institutions, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to innovate in the field of gene editing and immunotherapy.

Nautilus Biotech is a biotechnology company. The company has a pipeline of therapeutic proteins with improved profiles. The company's products include Belerofon, an injectable and orally available interferon alpha for use in the treatment of chronic Hepatitis C infection; and Vitatropin, an injectable and orally available human growth hormone (hGH) for use in the treatment of growth deficiencies. Nautilus Biotech S.A. sells therapeutic proteins, including interferons, hormones, growth factors, and enzymes in France and internationally. The company's protein engineering technology improves the pharmacology profile and administration route of blockbuster protein drugs. Nautilus Biotech S.A. was founded in 1999 and is based in Evry, France.

Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-Allâ„¢ to identify orthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-Allâ„¢ is able to address difficult GPCRs such as orphan and peptidic GPCRs.

Cellectis S.A. is a clinical-stage biotechnological company headquartered in Paris, France, focused on developing immuno-oncology products utilizing gene-edited T-cells that express chimeric antigen receptors to target cancer cells. The company's primary portfolio includes several allogeneic T-cell product candidates such as UCART19, designed for treating CD19-expressing hematologic malignancies, and UCART123 for acute myeloid leukemia. Additional candidates include ALLO-501 for relapsed/refractory diffuse large B-cell lymphoma, UCART22 for B-cell acute lymphoblastic leukemia, and products targeting multiple myeloma, such as UCARTCS1 and ALLO-715. In addition to its therapeutic developments, Cellectis also produces high oleic soybean oil and other agricultural products. The company has established strategic partnerships with various institutions, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to innovate in the field of gene editing and immunotherapy.